Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder

@article{Huang2011LongTermOW,
  title={Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder},
  author={Y. Huang and M. Tsai},
  journal={CNS Drugs},
  year={2011},
  volume={25},
  pages={539-554}
}
Attention-deficit hyperactivity disorder (ADHD), a common neuro-behavioural disorder characterized by inattention, hyperactivity and impulsivity, is a chronic disorder and often persists into adulthood. CNS stimulants have been the most well known treatment for ADHD for several decades due to their high effectiveness, good safety profiles and relatively minor adverse effects. Non-stimulant agents, including atomoxetine, extended-release guanfacine and extended-release clonidine (US FDA approved… Expand
View on Springer
ncbi.nlm.nih.gov
28 Citations
Background Citations
7
Results Citations
1

28 Citations

Citation Type

Citation Type

Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status
  • 20
The Potential Role of Neuroendocrine in Patients with Attention-Deficit/Hyperactivity Disorder
  • 5
  • PDF
Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?
  • 13
ReviewAttention deficit hyperactivity disorderTrastorno por déficit de atención con hiperactividad
  • PDF
Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial
Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
  • 8
Sweat it out? The effects of physical exercise on cognition and behavior in children and adults with ADHD: a systematic literature review
  • 55
  • PDF
Attention-deficit hyperactivity disorder and cardiac vagal control: a systematic review
  • 57
Gender Differences in the Behavioral Symptoms and Neuropsychological Performance of Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate: A Two-Year Follow-up Study.
  • 10
Attention-deficit hyperactivity disorder (ADHD) as a pyridoxine-dependent condition: urinary diagnostic biomarkers.
  • 17
...
1
2
3
...

References

SHOWING 1-10 OF 130 REFERENCES
Issues in the Management of Patients with Complex Attention-Deficit Hyperactivity Disorder Symptoms
  • 21
Attention-deficit hyperactivity disorder
  • 1,237
  • PDF
Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.
  • 188
Stimulant Medication Withdrawal During Long-term Therapy in Children With Comorbid Attention-Deficit Hyperactivity Disorder and Chronic Multiple Tic Disorder
  • 45
Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder.
  • 130
Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults
  • S. Wigal
  • Psychology, Medicine
  • CNS Drugs
  • 2009
  • 146
Two-year outcome of treatment with central stimulant medication in adult attention-deficit/hyperactivity disorder: a prospective study.
  • 53
First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants.
  • 47
Does stimulant therapy of attention‐deficit/hyperactivity disorder beget later substance abuse?
  • 759
  • PDF
Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
  • 187
  • PDF
...
1
2
3
4
5
...